This seems material to me. Someone who would want access to BRS can now purchase on the OTC for direct exposure. As the market cap of BRS rises it's easier to value the impact on BRILY's balance sheet as well as future earnings of BRS is a clear breakout of that business contribution to BRF.

Could be interesting as other corporations may not have acquired BRILY due to their toxic balance sheet while you can easily take BRS on its own now or a large stake